Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,840.90
-3.7 (-0.2%)
BSENSE

May 25

BSE+NSE Vol: 16.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
58,462.04
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
58,462.04
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
Raw Material Cost
7,389.02
6,449.10
6,904.33
7,777.57
7,049.12
6,153.13
5,515.23
Purchase of Finished goods
3,811.53
4,147.95
3,466.15
3,571.50
3,410.03
3,175.17
3,414.37
(Increase) / Decrease In Stocks
343.13
150.31
292.13
-686.91
-107.61
-638.22
300.85
Employee Cost
11,418.86
9,973.12
9,429.06
8,296.03
7,300.83
6,862.23
6,362.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
17,768.10
16,586.27
15,382.05
13,280.70
10,604.40
9,454.46
10,254.94
Total Expenditure (Excl Depreciation)
40,730.64
37,306.75
35,473.72
32,238.89
28,256.77
25,006.77
25,847.74
Operating Profit (PBDIT) excl Other Income
17,731.40
15,271.69
13,023.13
11,646.79
10,397.72
8,491.37
6,989.76
Other Income
1,971.72
1,965.04
1,354.19
634.52
921.51
835.52
635.98
Operating Profit (PBDIT)
19,703.12
17,236.73
14,377.32
12,281.31
11,319.23
9,326.89
7,625.74
Interest
338.91
231.36
238.47
172.00
127.35
141.43
302.73
Exceptional Items
-1,307.48
-677.85
-494.32
-171.45
-4,566.82
-4,306.14
-260.64
Gross Profit (PBDT)
18,056.73
16,327.52
13,644.53
11,937.86
6,625.06
4,879.32
7,062.37
Depreciation
2,937.85
2,575.39
2,556.64
2,529.43
2,143.74
2,079.95
2,052.78
Profit Before Tax
15,118.88
13,752.13
11,087.89
9,408.43
4,481.32
2,799.37
5,009.59
Tax
3,554.36
2,772.03
1,439.45
847.59
1,075.50
514.69
822.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11,564.52
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11,564.52
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
Share in Profit of Associates
-55.87
-15.35
-38.41
-47.90
-16.54
-12.33
-14.83
Minority Interest
-29.23
-35.71
-33.65
-39.36
-116.55
631.47
-407.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11,479.42
10,929.04
9,576.38
8,473.58
3,272.73
2,903.82
3,764.93
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
83,330.16
71,978.09
63,426.82
55,755.45
47,771.29
46,222.85
45,024.52
Earnings per share (EPS)
47.84
45.55
39.91
35.32
13.64
12.1
15.69
Diluted Earnings per share
47.8
45.6
39.9
35.3
13.6
12.1
15.69
Operating Profit Margin (Excl OI)
30.46%
29.35%
27.27%
26.91%
27.06%
25.55%
21.62%
Gross Profit Margin
31.01%
31.37%
28.57%
27.58%
17.24%
14.68%
21.85%
PAT Margin
19.86%
21.1%
20.2%
19.78%
8.86%
6.87%
12.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 11.19% vs 8.42% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 5.04% vs 14.12% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.11% vs 17.27% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 46.49% vs -2.98% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
58,462.04
10,560.00
47,902.04
453.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
58,462.04
10,560.00
47,902.04
453.62%
Raw Material Cost
7,389.02
4,378.00
3,011.02
68.78%
Purchase of Finished goods
3,811.53
0.00
3,811.53
(Increase) / Decrease In Stocks
343.13
-285.00
628.13
220.40%
Employee Cost
11,418.86
1,442.00
9,976.86
691.88%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17,768.10
1,584.00
16,184.10
1,021.72%
Total Expenditure (Excl Depreciation)
40,730.64
7,119.00
33,611.64
472.14%
Operating Profit (PBDIT) excl Other Income
17,731.40
3,441.00
14,290.40
415.30%
Other Income
1,971.72
507.00
1,464.72
288.90%
Operating Profit (PBDIT)
19,703.12
3,948.00
15,755.12
399.07%
Interest
338.91
23.00
315.91
1,373.52%
Exceptional Items
-1,307.48
-74.00
-1,233.48
-1,666.86%
Gross Profit (PBDT)
18,056.73
3,851.00
14,205.73
368.88%
Depreciation
2,937.85
463.00
2,474.85
534.52%
Profit Before Tax
15,118.88
3,388.00
11,730.88
346.25%
Tax
3,554.36
820.00
2,734.36
333.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
11,564.52
2,568.00
8,996.52
350.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
11,564.52
2,568.00
8,996.52
350.33%
Share in Profit of Associates
-55.87
0.00
-55.87
Minority Interest
-29.23
0.00
-29.23
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11,479.42
2,568.00
8,911.42
347.02%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
83,330.16
16,708.00
66,622.16
398.74%
Earnings per share (EPS)
47.84
96.91
-49.07
-50.63%
Diluted Earnings per share
47.80
96.75
-48.95
-50.59%
Operating Profit Margin (Excl OI)
30.46%
32.59%
0.00
-2.13%
Gross Profit Margin
31.01%
36.47%
0.00
-5.46%
PAT Margin
19.86%
24.32%
0.00
-4.46%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 58,462.04 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.19% vs 8.42% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 11,479.42 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.04% vs 14.12% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17,731.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.11% vs 17.27% in Mar 2025

Annual - Interest
Interest 338.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 46.49% vs -2.98% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.46%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025